SanBio, Inc., a leader in cell therapies for regenerative medicine, has announced the site initiation and opening of a Phase 1/2a clinical trial testing a novel cell therapy product, SB623, in patients suffering from disability resulting from ischemic stroke. The study is taking place at the University of Pittsburgh Medical Center...
The John Theurer Cancer Center at Hackensack University Medical Center, a top 50 U.S. News best hospital for cancer, is one of the first four clinical sites enrolling patients in a landmark study designed to uncover the molecular segments and variations of multiple myeloma...
Encouraging News For UK Patients With Metastatic Advanced Prostate Cancer
9/22/2011
Janssen has launched a new treatment method which has shown to extend life for some men suffering from advanced prostate cancer. The treatment option was discovered in the UK at The Institute of Cancer Research (ICR) in what is now Cancer Research UK Cancer Therapeutics Unit...
OncoHealth Corporation, a protein biomarker diagnostics company, announced new study data showing that the company's proprietary HPV E6 and E7 oncoprotein assays correlated with cervical disease grade and may distinguish cervical disease or cervical cancer from clinically insignificant HPV infection...
Niiki Pharma Inc. announced interim results from the ongoing Phase I clinical trial of its lead product, NKP-1339. NKP-1339 is a first-in-class transferrin targeted small molecule that down-regulates GRP78, a key regulator of mis-folded protein processing and a tumor survival factor...
Swedish's Ivy Brain Tumor Center Launches Two New Clinical Trials To Treat Brain Cancer
9/22/2011
The Swedish Neuroscience Institute today announced that the Ivy Brain Tumor Center has launched two separate clinical trials for treating brain cancer. The first trial (IND No. 10206, Protocol No. 020221, Study Agent: DCVax Brain Autologous Dendritic cells and GBM tumor lysate) sponsored by Northwest Biotherapeutics, Bothell, Wash...
Scientists Identify A Key Molecule That Blocks Abnormal Blood Vessel Growth In Tumors
9/22/2011
A new and better understanding of blood vessel growth and vascular development (angiogenesis) in cancer has been made possible by research carried out by a team of scientists from Moffitt Cancer Center, the University of Florida, Harvard University, Yale University and the Children's Hospital of Los Angeles...
First Recurrent Gene Fusion Identified In Ovarian Cancer
9/22/2011
Researchers studying ovarian cancer have discovered that, in a substantial fraction of ovarian tumors, a gene closely related to the estrogen receptor is broken and fused to an adjacent gene by a chromosome rearrangement; a finding that could shed light on how these deadly tumors develop and spread...
Differences In Gene Expression May Cause Higher Rates Of Prostate Cancer In African-American Men
9/22/2011
Genetic differences in prostate cells seem to be a root cause of the prostate cancer disparities between African-American men and white men, according to findings presented at the Fourth AACR Conference on The Science of Cancer Health Disparities, held here Sept. 18-21, 2011. Prostate cancer is the second most common cancer among U.S...
The John Theurer Cancer Center at Hackensack University Medical Center, a top 50 U.S. News best hospital for cancer, is one of the first four clinical sites enrolling patients in a landmark study designed to uncover the molecular segments and variations of multiple myeloma...